You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 134 No. 5, May 1999 TABLE OF CONTENTS
  Archives
  •  Online Features
  Original Article
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Citing articles on ISI (12)
 •Contact me when this article is cited
 Related Content
 •Related article
 •Similar articles in this journal
 Topic Collections
 •Surgery, Other
 •Alert me on articles by topic

Peritoneal Expansion by Artificially Produced Ascites During Perfusion Chemotherapy

Dimitris Tsiftsis, MD, PhD; Eelco de Bree, MD; John Romanos, MD; Anastasios Petrou, MD; Elias Sanidas, MD; John Askoxylakis, MD; Konstantinos Zervos, MD; Dimitris Michaloudis, MD

Arch Surg. 1999;134:545-549.

Hypothesis  In cases of peritoneal carcinomatosis, continuous hyperthermic peritoneal perfusion chemotherapy (CHPPC) accomplishes homogeneous distribution of the drug and heat to the entire peritoneal cavity and exposure of the visceral and parietal surfaces to the perfusate. A new closed technique for expansion that produces artificial ascites is safer for medical personnel because of less heat and drug loss and more efficacious in its hemodynamic effect on the patient.

Design  Prospective study.

Setting  University hospital.

Patients  Twenty-one patients with peritoneal carcinomatosis.

Interventions  We performed 23 continuous hyperthermic peritoneal perfusion chemotherapy (CHPPC) procedures with peritoneal cavity expansion to an intra-abdominal pressure up to 26 mm Hg, using artificially produced ascites with 4 to 9 L normal saline solution.

Main Outcome Measures  Intraoperative and postoperative complications and hemodynamic changes during CHPPC.

Results  No intraoperative complications were recorded. The artificially produced ascites did not cause significant hemodynamic changes. During the immediate postoperative period, 1 patient died of intra-abdominal hemorrhage and leakage of a colorectal anastomosis, resulting in a mortality rate of 4% in our series. Minor complications were seen in 14 patients. The complications were not attributable to the expansion technique.

Conclusions  Our proposed modification of closed-circuit CHPPC appears to be well tolerated and safe in patients with a high tumor load, as well as for the theater personnel. It remains to be investigated whether the theoretical advantages of the proposed technique will also lead to better long-term results.


From the Departments of Surgical Oncology (Drs Tsiftsis, de Bree, Romanos, Sanidas, Askoxylakis, and Zervos) and Anesthesiology (Drs Petrou and Michaloudis), Medical School, University of Crete, H[accent-me]rákleion.


RELATED ARTICLE

Invited Critique: Peritoneal Expansion by Artificially Produced Ascites During Perfusion Chemotherapy
John S. Spratt
Arch Surg. 1999;134(5):550.
EXTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Cytoreductive Surgery and Intraoperative Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel: A Clinical and Pharmacokinetic Study
deBree et al.
Ann. Surg. Oncol. 2008;15:1183-1192.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1999 American Medical Association. All Rights Reserved.